Skip to main content

Table 1 Characteristics of 69 male patients with ankylosing spondylitis in western Sweden

From: Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes

  n(%) Median (range) Mean ± SD
Age, years   48 (17, 78) 49 ± 15
Years since symptom onset   20 (2, 55) 23 ± 14
Present or past iritis 37 (54)   
Present or past synovitis 37 (54)   
Patients with a vertebral fracture 8 (12)   
mSASSS   8 (0, 72) 19 ± 21
BASMI, score   3.0 (1.0, 7.2) 3.2 ± 1.6
BASDAI, score   2.7 (0.2, 7.9) 3.1 ± 2.0
ASDAS, score   2.1 (1.0, 4.4) 2.3 ± 0.9
BAS-G   2.2 (0, 9.8) 3.0 ± 2.7
BASFI, score   2.0 (0, 8.7) 2.6 ± 2.2
ESR, mm/h   10 (2, 73) 14 ± 12
CRP, mg/L   5 (3, 71) 9 ± 12
HLA-B27 positive 65 (94)   
Patients taking NSAID 52 (75)   
Patients taking glucocorticoid 1 (1)   
Patients taking DMARD 21 (30)   
  Methotrexate 13 (19)   
  Sulfasalazine 5 (7)   
  TNF inhibitors 15 (22)   
  1. BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, BAS Functional Index; BASG1, BAS Patient Global score; BASMI, BAS Metrology Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; NSAID, nonsteroidal antiinflammatory drug; DMARD, disease-modifying antirheumatic drug; TNF, tumor necrosis factor; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score.